Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mu-type opioid receptor | ||
Ligand | BDBM50122538 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_145593 (CHEMBL749738) | ||
IC50 | >10000±n/a nM | ||
Citation | Hanessian, S; Parthasarathy, S; Mauduit, M; Payza, K The power of visual imagery in drug design. Isopavines as a new class of morphinomimetics and their human opioid receptor binding activity. J Med Chem46:34-48 (2002) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Mu-type opioid receptor | |||
Name: | Mu-type opioid receptor | ||
Synonyms: | M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1 | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 44789.51 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P35372 | ||
Residue: | 400 | ||
Sequence: |
| ||
BDBM50122538 | |||
n/a | |||
Name | BDBM50122538 | ||
Synonyms: | 16-methyl-17-azatetracyclo[7.6.2.02,7.010,15]heptadeca-2(7),3,5,12,14-pentaen-17-yl(phenyl)methane | ||
Type | Small organic molecule | ||
Emp. Form. | C24H25N | ||
Mol. Mass. | 327.462 | ||
SMILES | C[C@@H]1[C@@H]2C3=CC=CC[C@H]3[C@H](Cc3ccccc23)N1Cc1ccccc1 |wU:2.2,9.19,8.7,1.0,c:5,t:3,TLB:15:16:17.1:3.8,0:1:3.8:16.10.11,THB:12:11:17.1:3.8,18:17:3.8:16.10.11,7:8:17.1:16.10.11,(9.27,-.38,;7.84,-.93,;4.09,.32,;4.08,1.86,;4.08,3.4,;5.41,4.17,;6.74,3.41,;6.75,1.86,;5.41,1.09,;5.63,-2.78,;4.09,-2.78,;2.76,-2.01,;1.42,-2.78,;.09,-2.01,;.09,-.47,;1.42,.3,;2.76,-.47,;7.08,-2.27,;8.06,-3.44,;7.54,-4.88,;8.52,-6.05,;8.01,-7.5,;6.49,-7.78,;5.49,-6.59,;6.02,-5.14,)| | ||
Structure |